Loa loa filariasis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Changes made per Mahshid's request) |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
'''For patient information, click [[Loa loa filariasis (patient information)|here]]''' | |||
{{Loa loa filariasis}} | {{Loa loa filariasis}} | ||
{{CMG}} {{AE}} {{KD}} | {{CMG}} {{AE}} {{KD}} | ||
| Line 13: | Line 14: | ||
==[[Loa loa filariasis causes|Causes]]== | ==[[Loa loa filariasis causes|Causes]]== | ||
==[[Loa loa filariasis differential diagnosis|Differentiating Loa | ==[[Loa loa filariasis differential diagnosis|Differentiating Loa Loa Filariasis from other Diseases]]== | ||
==[[Loa loa filariasis epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Loa loa filariasis epidemiology and demographics|Epidemiology and Demographics]]== | ||
| Line 25: | Line 26: | ||
==Treatment== | ==Treatment== | ||
[[Loa loa filariasis medical therapy|Medical Therapy]] | [[Loa loa filariasis surgery|Surgery]] | [[Loa loa filariasis primary prevention|Primary Prevention]] | [[Loa loa filariasis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Loa loa filariasis future or investigational therapies|Future or Investigational Therapies]] | [[Loa loa filariasis medical therapy|Medical Therapy]] | [[Loa loa filariasis surgery|Surgery]] | [[Loa loa filariasis primary prevention|Primary Prevention]] | [[Loa loa filariasis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Loa loa filariasis future or investigational therapies|Future or Investigational Therapies]] | ||
:* '''Cutaneous filariasis - Loa loa, onchocercia volvulus'''<ref name="pmid20739055">{{cite journal| author=Taylor MJ, Hoerauf A, Bockarie M| title=Lymphatic filariasis and onchocerciasis. | journal=Lancet | year= 2010 | volume= 376 | issue= 9747 | pages= 1175-85 | pmid=20739055 | doi=10.1016/S0140-6736(10)60586-7 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20739055 }} </ref><ref name="pmid22632644">{{cite journal| author=Knopp S, Steinmann P, Hatz C, Keiser J, Utzinger J| title=Nematode infections: filariases. | journal=Infect Dis Clin North Am | year= 2012 | volume= 26 | issue= 2 | pages= 359-81 | pmid=22632644 | doi=10.1016/j.idc.2012.02.005 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22632644 }} </ref> | |||
::* Preferred regimen (1): [[Doxycycline]] 150 μg/kg single dose | |||
::* Preferred regimen (2): ([[Doxycycline]] 100 mg PO qd for 6 weeks {{or}} 200 mg PO qd for 4 weeks) {{then}} [[Ivermectin]] after 4-6 months 150 μg/kg single dose | |||
::* Preferred regimen (3): [[Doxycycline]] 200 mg PO qd for 6 weeks {{then}} [[Ivermectin]] after 4-6 months 150 μg/kg single dose | |||
==Case Studies== | ==Case Studies== | ||
[[Loa loa filariasis case study one|Case #1]] | [[Loa loa filariasis case study one|Case #1]] | ||
==External | ==External Links== | ||
* | * [http://www.cdc.gov/parasites/loiasis/ CDC Fact Sheet] | ||
[[Category:Parasitic diseases]] | [[Category:Parasitic diseases]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
| Line 42: | Line 42: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
<br> | <br> | ||
| Line 53: | Line 53: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
==References== | |||
{{reflist|2}} | |||
Latest revision as of 18:12, 18 September 2017
For patient information, click here
|
Loa Loa Filariasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Loa loa filariasis On the Web |
|
American Roentgen Ray Society Images of Loa loa filariasis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]
Synonyms and keywords: African eye worm; loaiasis; loiasis; loaina; filaria loa; filaria lacrimalis; filaria subconjunctivalis; fugitive swellings; microfilaria diurnal
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Loa Loa Filariasis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
-
- Preferred regimen (1): Doxycycline 150 μg/kg single dose
- Preferred regimen (2): (Doxycycline 100 mg PO qd for 6 weeks OR 200 mg PO qd for 4 weeks) THEN Ivermectin after 4-6 months 150 μg/kg single dose
- Preferred regimen (3): Doxycycline 200 mg PO qd for 6 weeks THEN Ivermectin after 4-6 months 150 μg/kg single dose
Case Studies
External Links
References
- ↑ Taylor MJ, Hoerauf A, Bockarie M (2010). "Lymphatic filariasis and onchocerciasis". Lancet. 376 (9747): 1175–85. doi:10.1016/S0140-6736(10)60586-7. PMID 20739055.
- ↑ Knopp S, Steinmann P, Hatz C, Keiser J, Utzinger J (2012). "Nematode infections: filariases". Infect Dis Clin North Am. 26 (2): 359–81. doi:10.1016/j.idc.2012.02.005. PMID 22632644.